- Home
- AVX vs KRSA Comparison
AVX vs KRSA Comparison
Compare AVX & KRSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVX | KRSA |
|---|---|---|
| Founded | 2017 | 2024 |
| Country | United States | United States |
| Employees | 7 | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.8M | 1.5B |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | AVX | KRSA |
|---|---|---|
| Price | $4.19 | $31.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $44.00 |
| AVG Volume (30 Days) | ★ 329.4K | 112.3K |
| Earning Date | 11-13-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.55 | 8.26 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,340,811.00 | $2,074,000.00 |
| Revenue This Year | $18,042.77 | N/A |
| Revenue Next Year | $12.21 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 3348.10 | 3.70 |
| 52 Week Low | $0.35 | $29.03 |
| 52 Week High | $7.38 | $37.27 |
Technical Indicators
Market Signals| Indicator | AVX | KRSA |
|---|---|---|
| Relative Strength Index (RSI) | 43.34 | 45.24 |
| Support Level | $3.02 | $29.98 |
| Resistance Level | $6.25 | $36.30 |
| Average True Range (ATR) | 0.69 | 2.56 |
| MACD | -0.20 | 0.04 |
| Stochastic Oscillator | 7.05 | 34.98 |
Price Performance
Historical ComparisonAbout AVX Avax One Technology Ltd.
AVAX One Technology Ltd is a digital infrastructure company focused on digital asset and computing infrastructure. The Company builds modular data centers in regions with access to energy resources, using behind-the-meter generation and microgrid design to provide compute capacity for AI and high-performance computing (HPC) workloads. In addition, the company mines Bitcoin in Alberta and Ohio, operating at a hashrate of approximately 300 PH/s. The Company also maintains an Avalanche digital asset treasury, accumulating AVAX and generating onchain yield through native staking and ecosystem participation.
About KRSA Korsana Biosciences Inc. Common Stock
Korsana Biosciences Inc is a biopharmaceutical company developing therapeutics to treat neurodegenerative diseases beginning with Alzheimer's disease (AD. The company's flagship product candidate, KRSA-028, is an anti-amyloid beta antibody that combines the proprietary Therapeutic Targeting (THETA) platform with well-validated aspects from other anti-Ab products that have achieved regulatory approval or are in late-stage clinical trials.